(Press-News.org) PHILADELPHIA — Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according to the results of a phase II study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
"Giant-cell tumor of the bone is a rare tumor that affects mostly young people," said Sant P. Chawla, M.D., director of the Santa Monica Oncology Center, Santa Monica, Calif. "Radical surgery is currently the only treatment option. In our study, the use of denosumab allowed patients to avoid radical surgery and prevented recurrence. We hope that in the future, its use may make it possible to avoid surgery completely."
Giant-cell tumor of the bone is a benign tumor characterized by giant cells that are positive for the protein RANK ligand, which helps promote bone destruction. Currently, the only treatment option for patients with giant-cell tumor of the bone is surgery. However, patients who undergo surgery often have recurrent disease or significant morbidity, such as amputation. In addition, 25 to 30 percent of patients with this tumor have to undergo joint replacements.
Chawla and colleagues conducted this phase II study to explore the mechanism of action of denosumab, an inhibitor of RANK ligand, in the treatment of giant-cell tumor of the bone.
Twenty adult patients with recurrent or unresectable giant-cell tumor of the bone were treated with subcutaneous denosumab every four weeks. After treatment, all 20 of the patients had a decrease in giant cells of 90 percent or greater, an indicator of a reduction of tumor burden. In addition, results indicated that 65 percent of the patients had new bone growth in areas where the RANK ligand had previously caused bone destruction.
"A majority of patients with giant-cell tumor of the bone are young and have to get joint replacements, which last 15 to 20 years before a repeat surgery is needed," Chawla said. "Now, we hopefully can do minimal surgery, avoiding a joint replacement and recurrence."
One of the next steps in evaluating denosumab for giant-cell tumor of the bone is a much larger, multinational study that is currently enrolling patients. In addition, Chawla hopes to evaluate the use of denosumab as a presurgery, or neoadjuvant, treatment as well.
"In the future we hope to investigate giving the drug prior to surgery to see the effect it has, then remove the tumor and evaluate the pathological response," Chawla said.
This study was funded by Amgen.
###
Follow the AACR on Twitter: @aacr #aacr
Follow the AACR on Facebook: http://www.facebook.com/aacr.org
About the AACR
Founded in 1907, the American Association for Cancer Research (AACR) is the world's first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR's membership includes 34,000 laboratory, translational and clinical researchers; population scientists; other health care professionals; and cancer advocates residing in more than 90 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis and treatment of cancer by annually convening more than 20 conferences and educational workshops, the largest of which is the AACR Annual Meeting with more than 17,000 attendees. In addition, the AACR publishes seven peer-reviewed scientific journals and a magazine for cancer survivors, patients and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the Scientific Partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration and scientific oversight of individual and team science grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and policymakers about the value of cancer research and related biomedical science in saving lives from cancer.
For more information about the AACR, visit www.AACR.org.
Denosumab reduces burden of giant-cell tumor of the bone
2012-09-21
ELSE PRESS RELEASES FROM THIS DATE:
Horticultural hijacking
2012-09-21
It's a battleground down there — in the soil where plants and bacteria dwell.
Even though beneficial root bacteria come to the rescue when a plant is being attacked by pathogens, there's a dark side to the relationship between the plant and its white knight.
According to research reported by a University of Delaware scientific team in the September online edition of Plant Physiology, the most highly cited plant journal, a power struggle ensues as the plant and the "good" bacteria vie over who will control the plant's immune system.
"For the brief period when the beneficial ...
Virtual boundaries: How environmental cues affect motivation and task-oriented behavior
2012-09-21
NEW YORK - September 21, 2012 - Much of our daily lives are spent completing tasks that involve a degree of waiting, such as remaining on hold while scheduling a doctor's appointment or standing in line at an ATM. Faced with a wait, some people postpone, avoid, or abandon their task. Others endure the wait but feel dissatisfied and frustrated by the experience.
Are there ways to improve our outlook and mindset while waiting? A new study shows that seemingly irrelevant environmental cues—such as queue guides, or barriers commonly used in banks and airports—can serve as ...
Historian uncovers rare writings by 18th century political icon
2012-09-21
Three political essays by one of the greatest British statesmen of the last 250 years have been discovered by a historian at Queen Mary, University of London.
The new finds constitute the earliest political writings by Edmund Burke (1729-97), dating from around 1757, when he was 27-years-old, a period often described as the 'missing years' of his biography.
Professor Richard Bourke, from the School of History at Queen Mary, came across the early essays among a series of notebooks belonging to William Burke, a close friend and distant relation of parliamentarian, Edmund. ...
Mount Sinai researchers identify predictors for inpatient pain
2012-09-21
Researchers from Mount Sinai School of Medicine have identified reliable predictors of pain by surveying patients throughout their hospital stays about the severity of their pain and their levels of satisfaction with how their pain was managed by hospital staff. Using this data, interdisciplinary teams treating patients were able to identify patients at higher risk for pain prior to, or immediately upon, their admission to the hospital, and create and implement intervention plans resulting in patients reporting lower levels of pain and higher levels of satisfaction with ...
Documenting women's experiences with chromosome abnormalities found in new prenatal test
2012-09-21
PHILADELPHIA – We often hear that "knowledge is power." But, that isn't always the case, especially when the knowledge pertains to the health of an unborn child, with murky implications, at best. A new study, led by researchers from the Perelman School of Medicine at the University of Pennsylvania, begins to document this exception to the general rule.
Barbara Bernhardt, MS, CGC, a genetic counselor at the Hospital of the University of Pennsylvania, and colleagues contacted a small group of women who are participating in a larger Columbia University study investigating ...
Addictive properties of drug abuse may hold key to an HIV cure
2012-09-21
TALLAHASSEE, Fla. — A Florida State University researcher is on a mission to explore the gene-controlling effects of addictive drugs in pursuit of new HIV treatments.
Working under the support of a $1.8 million grant from the National Institutes of Health (NIH), Florida State biologist Jonathan Dennis is studying a unique ability shared between a promising class of HIV treatments known as histone deacetylase inhibitors (HDIs) and psychostimulant drugs such as cocaine.
"Current HIV treatments do just that — they treat the disease by preventing the spread of HIV in ...
How do we make moral judgments? Insights from Psychological Science
2012-09-21
New research published in Psychological Science, a journal of the Association for Psychological Science, provides intriguing insights into some of the factors that influence how we make moral judgments.
Reappraising Our Emotions Allows Cooler Heads to Prevail
We might like to think that our judgments are always well thought-out, but research suggests that our moral judgments are often based on intuition. Our emotions seem to drive our intuitions, giving us the gut feeling that something is 'right' or 'wrong.' In some cases, however, we seem to be able to override these ...
'Forest killer' plant study explores rapid environmental change factors
2012-09-21
TEMPE (Sept. 21, 2012) - It's called mile-a-minute weed or "forest killer." Mikania micrantha is an exotic, invasive species that spreads quickly, covering crops, smothering trees and rapidly altering the environment.
Researchers at Arizona State University are spearheading a four-year research project that will explore what factors cause people and the environment to be vulnerable to rapid environmental change, such as an invasion by Mikania. Study findings likely will serve as a harbinger of the future as humans increasingly experience abrupt, extreme conditions associated ...
Study shows anaesthetic-related deaths reduced dramatically
2012-09-21
LONDON, ON – A team of researchers led by London's Dr. Daniel Bainbridge have compiled data from 87 studies worldwide that shows post-anaesthetic deaths have declined as much as 90 percent since before the 1970s. During the same period, the risk of dying from any cause within 48 hours of surgery has decreased by 88 percent. The study covered outcomes in both developed and developing countries, with the findings published in the current issue of the high-profile journal The Lancet.
The study calls for use of evidence-based interventions to reduce the disparities between ...
Research identifies protein that regulates key 'fate' decision in cortical progenitor cells
2012-09-21
Cold Spring Harbor, NY – Researchers at Cold Spring Harbor Laboratory (CSHL) have solved an important piece of one of neuroscience's outstanding puzzles: how progenitor cells in the developing mammalian brain reproduce themselves while also giving birth to neurons that will populate the emerging cerebral cortex, the seat of cognition and executive function in the mature brain.
CSHL Professor Linda Van Aelst, Ph.D., and colleagues set out to solve a particular mystery concerning radial glial cells, or RGCs, which are progenitors of pyramidal neurons, the most common type ...